BIOMARIN PHARMACEUTICAL INC Prepaid Expense, Current
BIOMARIN PHARMACEUTICAL INC (BMRN) had Prepaid Expense, Current of $27.96 million as of 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2016-02-29
- 2015-12-31: Prepaid Expense, Current $27.96M.
- 2015-09-30: Prepaid Expense, Current $73.17M.
- 2015-06-30: Prepaid Expense, Current $36.17M.
- 2015-03-31: Prepaid Expense, Current $39.16M.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2015-12-31 | $27.96M 10-K · filed 2016-02-29 | |
| 2015-09-30 | $73.17M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $36.17M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $39.16M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $35.39M 10-K · filed 2016-02-29 | $28.86M 10-K · filed 2015-03-02 |
| 2013-12-31 | $21.14M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $11.41M 10-Q · filed 2012-10-29 | |
| 2012-06-30 | $14.87M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $12.11M 10-Q · filed 2012-04-30 | |
| 2011-12-31 | $7.55M 10-Q · filed 2012-10-29 | |
| 2011-09-30 | $14.95M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $14.43M 10-Q · filed 2011-08-01 | |
| 2010-12-31 | $8.45M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |